Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Revenue of Prenetics Global Limited (PRE)
Revenue in 2023 (TTM): $21.74 M
According to Prenetics Global Limited's latest financial reports the company's current revenue (TTM) is $21.74 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Prenetics Global Limited
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $21.74 M | $8.83 M | $-47,896,099 | $-56,669,031 | $-62,723,871 |
| 2022 | $275.76 M | $131.55 M | $-214,282,419 | $-183,306,283 | $-190,453,387 |
| 2021 | $275.85 M | $106.13 M | $-157,699,427 | $-170,284,098 | $-174,016,842 |
| 2020 | $65.18 M | $26.34 M | $-1,415,840 | $-3,901,443 | $-1,963,885 |
| 2019 | $9.23 M | $2.72 M | $-18,568,697 | $-20,872,675 | $-20,195,201 |